Achilles therapeutics reports fourth quarter and year-end 2022 financial results and recent business highlights

- demonstrated early proof-of-concept for cnet therapy in heavily pre-treated advanced nsclc patients -
ACHL Ratings Summary
ACHL Quant Ranking